Literature DB >> 1884533

Surface osteosarcoma.

A K Raymond1.   

Abstract

Osteosarcoma arising on the periosteal aspect of bone comprises a biologically heterogeneous group of neoplasms. The group as a whole may be referred to by a single descriptive term that emphasizes their common site of origin and underscores their malignant osteogenic potential: surface osteosarcoma. Its biologic heterogeneity may be approached via a number of avenues. Detailed description of individual tumors and grading are frequently employed. However, implementation of a classification system based upon reproducible clinical, roentgenographic, macroscopic, and histologic parameters is advantageous. The suggested classification system serves to clearly define parosteal and periosteal osteosarcoma, as well as recognize unusual variants. Most important, it defines therapeutic strategy. The classification system identifies low-grade, biologically indolent forms (i.e., parosteal osteosarcoma and periosteal osteosarcoma) that are best treated by surgery alone. At the same time, it recognizes high-grade forms with significant potential for life-threatening behavior (i.e., 'dedifferentiated' parosteal osteosarcoma and high-grade surface osteosarcoma) that are best managed by multimodality therapy incorporating chemotherapy and surgery.

Entities:  

Mesh:

Year:  1991        PMID: 1884533

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  7 in total

1.  High malignant surface osteosarcoma arising at the site of a previously treated aneurysmal bone cyst.

Authors:  P Wuisman; A Roessner; S Blasius; J Grünert; T Vestering; W Winkelmann
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Dedifferentiated parosteal osteosarcoma with well-differentiated metastases.

Authors:  Katsuhito Takeuchi; Takeshi Morii; Hiroo Yabe; Hideo Morioka; Makio Mukai; Yoshiaki Toyama
Journal:  Skeletal Radiol       Date:  2006-03-01       Impact factor: 2.199

Review 3.  Common musculoskeletal tumors of childhood and adolescence.

Authors:  Carola A S Arndt; Peter S Rose; Andrew L Folpe; Nadia N Laack
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

4.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

5.  Small cell osteosarcoma of the soft tissue.

Authors:  L H Robinson; M J Pitt; K A Jaffe; G P Siegal
Journal:  Skeletal Radiol       Date:  1995-08       Impact factor: 2.199

6.  Parosteal osteosarcoma of the fibula in a middle-aged patient: A case report.

Authors:  Guiping Chen; Qiang Xu; Bin Zhang; Min Dai
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

7.  Surface osteosarcoma: Clinical features and therapeutic implications.

Authors:  H Nouri; M Ben Maitigue; L Abid; N Nouri; A Abdelkader; M Bouaziz; M Mestiri
Journal:  J Bone Oncol       Date:  2015-11-10       Impact factor: 4.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.